Tag Archives: EGOV

Top 10 Medical Stocks To Buy For 2019

InVitae (NYSE: NVTA) and Natera (NASDAQ:NTRA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.

Risk and Volatility

Get InVitae alerts:

InVitae has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Natera has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.

Profitability

This table compares InVitae and Natera’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
InVitae -154.96% -127.38% -68.70%
Natera -58.84% -752.93% -66.23%

Institutional and Insider Ownership

Top 10 Medical Stocks To Buy For 2019: The Charles Schwab Corporation(SCHW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Charles Schwab (SCHW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Charles Schwab (NYSE:SCHW) had its target price cut by analysts at Credit Suisse Group from $62.00 to $61.00 in a research report issued on Monday. The firm presently has an “outperform” rating on the financial services provider’s stock. Credit Suisse Group’s price target would indicate a potential upside of 10.63% from the company’s current price.

  • [By Stephan Byrd]

    BlackRock (NYSE: BLK) and Charles Schwab Co. Common Stock (NYSE:SCHW) are both large-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk.

  • [By Stephan Byrd]

    Zurcher Kantonalbank Zurich Cantonalbank grew its position in Charles Schwab Co. (NYSE:SCHW) by 1.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 253,187 shares of the financial services provider’s stock after acquiring an additional 2,700 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Charles Schwab were worth $13,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By Ethan Ryder]

    Rockefeller Capital Management L.P. purchased a new stake in shares of Charles Schwab Co. (NYSE:SCHW) in the first quarter, HoldingsChannel.com reports. The institutional investor purchased 11,591 shares of the financial services provider’s stock, valued at approximately $605,000.

Top 10 Medical Stocks To Buy For 2019: Contango Oil & Gas Company(MCF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION NOTICE: “Contango Oil & Gas (MCF) Short Interest Update” was originally published by Ticker Report and is owned by of Ticker Report. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at www.tickerreport.com/banking-finance/3346537/contango-oil-gas-mcf-short-interest-update.html.

Top 10 Medical Stocks To Buy For 2019: Orezone Gold Corp (ORE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Galactrum (ORE) is a PoW/PoS coin that uses the
    Lyra2RE hashing algorithm. It launched on November 11th, 2017. Galactrum’s total supply is 2,092,679 coins and its circulating supply is 1,372,679 coins. Galactrum’s official Twitter account is @galactrum. Galactrum’s official website is galactrum.org.

Top 10 Medical Stocks To Buy For 2019: Banco De Chile(BCH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Banco de Chile (NYSE: BCH) and Cr AGRICOLE S A/ADR (OTCMKTS:CRARY) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

  • [By Shane Hupp]

    Bitcoin Cash (CURRENCY:BCH) traded down 1.5% against the dollar during the 24 hour period ending at 19:00 PM E.T. on May 19th. During the last week, Bitcoin Cash has traded down 18.1% against the dollar. One Bitcoin Cash coin can now be bought for $1,184.65 or 0.14390800 BTC on major exchanges including fex, Koinex, DSX and Bitfinex. Bitcoin Cash has a total market cap of $20.30 billion and approximately $598.31 million worth of Bitcoin Cash was traded on exchanges in the last 24 hours.

Top 10 Medical Stocks To Buy For 2019: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Joseph Griffin]

    NIC Inc. (NASDAQ:EGOV) has been given a consensus recommendation of “Hold” by the ten research firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $18.00.

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

  • [By Max Byerly]

    Shares of NIC Inc. (NASDAQ:EGOV) have earned a consensus rating of “Hold” from the ten analysts that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $18.00.

  • [By Joseph Griffin]

    Media headlines about NIC (NASDAQ:EGOV) have been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. NIC earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news headlines about the software maker an impact score of 44.2220263592641 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Medical Stocks To Buy For 2019: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Max Byerly]

    Verition Fund Management LLC bought a new position in shares of Guidewire Software Inc (NYSE:GWRE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,731 shares of the technology company’s stock, valued at approximately $221,000.

  • [By Ethan Ryder]

    Shares of Guidewire Software Inc (NYSE:GWRE) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $96.19 and last traded at $94.10, with a volume of 46042 shares trading hands. The stock had previously closed at $95.82.

  • [By Logan Wallace]

    Guidewire Software Inc (NYSE:GWRE) shares reached a new 52-week high and low during mid-day trading on Wednesday . The company traded as low as $95.26 and last traded at $93.56, with a volume of 7356 shares changing hands. The stock had previously closed at $94.77.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Insider Selling: Guidewire Software (GWRE) Insider Sells 209 Shares of Stock” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3365485/insider-selling-guidewire-software-gwre-insider-sells-209-shares-of-stock.html.

  • [By Garrett Baldwin]

    Starbuck’s Corp.(Nasdaq: SBUX) Executive Chair Howard Schultz announced he will depart the company. Many are speculating he will pursue a career in politics and potentially seek the Democratic nomination for president in 2020. Schultz had previously denied any speculation around a role in government; but his recent comments suggest that “public service” will be a part of his future plans. Gold prices dipped below $1,300 per ounce as markets continue to speculate on the likelihood of additional interest rate hikes in 2018. We believe this is solid buying opportunity for investors. The reason why gold is going to get a nice boost: ongoing trade tensions between the United States and the rest of the globe. Money Morning Resource SpecialistPeter Krauth provides his insight on where gold prices are heading nextand how you can make big gains in the weeks ahead.
    Three Stocks to Watch Today: AAPL, TWTR, SCGLF
    Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the world’s first $1 trillion company. The stock pushed above $192.60 per share in pre-market hours after its first day at the Worldwide Developers Conference. During the event, the company unveiled its new mobile operating system, called iOS 12. The firm also unveiled a suite of tools designed to combat technology addiction. Shares of Twitter Inc. (NYSE: TWTR) jumped nearly 4% on news that the social media company is about to join the S&P 500. The company will join on Thursday morning and will replace agribusiness giant Monsanto Co. (NYSE: MON). The news comes as Monsanto is in the final steps of its merger with German chemical giant Bayer AG (Nasdaq: BAYRY). Shares of Societe Generale SA (ADR) (OTCMKTS: SCGLF) are in focus after the U.S. Justice Department announced the French investment bank will pay $1.3 billion to settle two ongoing legal headaches. The company bribed Libyan officials and manipulated LIBOR, a benchmark interest rate on which most financing is based. Legg Mason Inc. (NYSE: L

Top 10 Medical Stocks To Buy For 2019: Two River Bancorp(TRCB)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Two Rivers Bancorp (NASDAQ:TRCB) have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Two Rivers Bancorp earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.3815117771449 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 Medical Stocks To Buy For 2019: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Carter’s, Inc. (NYSE:CRI) has earned a consensus recommendation of “Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have given a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $120.27.

  • [By Joseph Griffin]

    UBS Group initiated coverage on shares of Carter’s (NYSE:CRI) in a research note published on Thursday morning, www.benzinga.com reports. The firm issued a neutral rating and a $114.00 price target on the textile maker’s stock.

  • [By Steve Symington]

    Carter’s Inc.(NYSE:CRI)announced first-quarter 2018 results on Thursday morning, detailing a strong performance in spite of the negative impact of the recent bankruptcy of Toy “R” Us on its large wholesale segment. Though shares initially fell almost 5% early on, Carter’s stock recovered to trade modestly higher by this afternoon.

  • [By Joseph Griffin]

    Carter’s, Inc. (NYSE:CRI) was the recipient of some unusual options trading activity on Tuesday. Stock investors purchased 2,108 put options on the company. This represents an increase of approximately 1,560% compared to the average daily volume of 127 put options.

  • [By Max Byerly]

    Dimensional Fund Advisors LP grew its holdings in shares of Carter’s, Inc. (NYSE:CRI) by 2.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 450,812 shares of the textile maker’s stock after purchasing an additional 9,306 shares during the period. Dimensional Fund Advisors LP owned approximately 0.96% of Carter’s worth $46,930,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Buy For 2019: CubeSmart(CUBE)

Advisors’ Opinion:

  • [By Shane Hupp]

    DigiCube (CURRENCY:CUBE) traded 50.6% lower against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 17th. One DigiCube coin can now be purchased for $0.0001 or 0.00000001 BTC on cryptocurrency exchanges. DigiCube has a market capitalization of $157,100.00 and approximately $21,384.00 worth of DigiCube was traded on exchanges in the last 24 hours. During the last seven days, DigiCube has traded 38% lower against the U.S. dollar.

  • [By Max Byerly]

    DigiCube (CURRENCY:CUBE) traded flat against the US dollar during the 24-hour period ending at 11:00 AM E.T. on July 7th. One DigiCube coin can now be purchased for about $0.0001 or 0.00000001 BTC on popular exchanges. During the last seven days, DigiCube has traded up 3.3% against the US dollar. DigiCube has a total market cap of $159,738.00 and $0.00 worth of DigiCube was traded on exchanges in the last day.

  • [By Shane Hupp]

    DigiCube (CUBE) uses the hashing algorithm. It launched on March 12th, 2016. DigiCube’s total supply is 2,429,126,009 coins. DigiCube’s official Twitter account is @PurePoS. DigiCube’s official website is www.freestaking.com.

  • [By Stephan Byrd]

    DigiCube (CURRENCY:CUBE) traded down 0.3% against the US dollar during the twenty-four hour period ending at 12:00 PM ET on June 23rd. During the last week, DigiCube has traded down 51.9% against the US dollar. DigiCube has a total market capitalization of $149,052.00 and $2.00 worth of DigiCube was traded on exchanges in the last 24 hours. One DigiCube coin can now be purchased for $0.0001 or 0.00000001 BTC on cryptocurrency exchanges.

  • [By Stephan Byrd]

    DigiCube (CURRENCY:CUBE) traded flat against the dollar during the 24-hour period ending at 18:00 PM ET on June 28th. DigiCube has a total market capitalization of $148,754.00 and approximately $0.00 worth of DigiCube was traded on exchanges in the last day. One DigiCube coin can currently be purchased for about $0.0001 or 0.00000001 BTC on popular cryptocurrency exchanges. Over the last week, DigiCube has traded down 8.6% against the dollar.

Top 10 Medical Stocks To Buy For 2019: Semgroup Corporation(SEMG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    SemGroup (NYSE:SEMG) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

    Signet Jewelers (NYSE:SIG) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

  • [By Stephan Byrd]

    SemGroup (NYSE: SEMG) and Halliburton (NYSE:HAL) are both oils/energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

  • [By Logan Wallace]

    Barclays PLC grew its holdings in SemGroup Corp (NYSE:SEMG) by 32.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 20,779 shares of the pipeline company’s stock after purchasing an additional 5,090 shares during the period. Barclays PLC’s holdings in SemGroup were worth $444,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    SemGroup (NYSE: SEMG) and Halliburton (NYSE:HAL) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability.

Best Medical Stocks To Watch Right Now

ReWalk Robotics (NASDAQ: RWLK) and Invacare (NYSE:IVC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, valuation, profitability, analyst recommendations, earnings and dividends.

Risk & Volatility

Get ReWalk Robotics alerts:

ReWalk Robotics has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Invacare has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500.

Dividends

Invacare pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. ReWalk Robotics does not pay a dividend. Invacare pays out -2.6% of its earnings in the form of a dividend.

Valuation & Earnings

This table compares ReWalk Robotics and Invacare’s top-line revenue, earnings per share (EPS) and valuation.

Best Medical Stocks To Watch Right Now: Energy Transfer Equity, L.P.(ETE)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Management teams tend to be very coy about what they’re working on behind closed doors. Energy Transfer Equity’s (NYSE:ETE) leadership, on the other hand, was very transparent about what’s going on behind the scenes during the company’s first-quarter conference call. They openly answered analysts’ questions, which provided investors with an interesting glimpse into what’s ahead.

  • [By Matthew DiLallo]

    Like last quarter, Energy Transfer Partners delivered strong earnings and cash flow growth. Because of that, the company was able to cover its jaw-dropping 12.4%-yielding distribution by a healthy 1.15 times. That slight decline from the year-ago quarter was caused by parent companyEnergy Transfer Equity (NYSE:ETE)significantly reducing its support. For a better comparison, the coverage ratio would have still been a solid 1.1 in this year’s first quarter without any assistance from Energy Transfer Equity, while it would have been a worrisome 0.98 in the year-ago period without the parent company’s help. That improvement isexactly what investors wanted to see this quarter.

  • [By Stephan Byrd]

    D.A. Davidson & CO. reduced its stake in Energy Transfer Equity (NYSE:ETE) by 10.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,328 shares of the pipeline company’s stock after selling 5,550 shares during the period. D.A. Davidson & CO.’s holdings in Energy Transfer Equity were worth $658,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    One reason investors are worried that Energy Transfer might need to reduce its distribution is that the company barely generates enough cash flow to support it without the help of its parent Energy Transfer Equity (NYSE:ETE). In 2017, Energy Transfer Partners produced $4.19 billion in distributable cash flow and would have paid out $4.15 billion to investors if it wasn’t for the fact that Energy Transfer Equity relinquished its rights to $656 million of that cash. While that support boosted the distribution coverage ratio from a tight 1.0 times to a more comfortable 1.2 times, it was only a temporary fix since Energy Transfer Equity’s support will diminish significantly in 2018 before declining further in 2019 and 2020.

Best Medical Stocks To Watch Right Now: EnLink Midstream Partners, LP(ENLK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on EnLink Midstream Partners (ENLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ValuEngine upgraded shares of EnLink Midstream Partners (NYSE:ENLK) from a strong sell rating to a sell rating in a research report released on Thursday morning.

Best Medical Stocks To Watch Right Now: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Best Medical Stocks To Watch Right Now: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

Best Medical Stocks To Watch Right Now: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Keith Noonan, Rich Smith, and Timothy Green]

    With that in mind, we asked three Motley Fool investors to profile an income-generating stock that’s currently flying under the radar but has some truly amazing qualities. Read on to see why they thinkNielsen Holdings (NYSE:NLSN), Vail Resorts (NYSE:MTN), and The Walt Disney Company (NYSE:DIS)are top dividend stocks that aren’t getting their due.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    Get GGP alerts:

    Read This Before Trade: Facebook, Inc. (FB), GGP Inc. (GGP) (nmsunews.com) Ggp Inc (GGP)’s Weekly Performance of -0.90% Is Nothing to Write Home About (parkcitycaller.com) Is GGP Inc (NYSE:GGP) A Good Dividend Stock? (finance.yahoo.com) GGP (GGP) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com) Dazzling Stocks: GGP Inc. (NYSE:GGP), Nielsen Holdings plc (NYSE:NLSN), AmerisourceBergen Corporation (NYSE … (thestreetpoint.com)

    GGP has been the subject of a number of recent research reports. Royal Bank of Canada restated a “buy” rating and set a $24.00 target price on shares of GGP in a research report on Monday, February 12th. Boenning Scattergood reissued a “buy” rating and issued a $35.00 target price on shares of GGP in a research note on Tuesday, March 27th. Mizuho raised GGP from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, March 19th. Zacks Investment Research upgraded GGP from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Wednesday, April 11th. Finally, Barclays cut their price target on GGP from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. GGP currently has an average rating of “Hold” and a consensus price target of $24.92.

  • [By Joseph Griffin]

    ARP Americas LP grew its position in Nielsen Holdings (NYSE:NLSN) by 41.2% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 14,400 shares of the business services provider’s stock after buying an additional 4,200 shares during the period. ARP Americas LP’s holdings in Nielsen were worth $458,000 as of its most recent SEC filing.

Best Medical Stocks To Watch Right Now: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Top 10 Warren Buffett Stocks To Own Right Now

Move over Warren Buffett! Amazon CEO Jeff Bezos is now the second richest person on Earth.

The latest tally by Bloomberg’s Billionaires Index shows Bezos is now worth about $75.6 billion. Another ranking compiled by Forbes has Bezos’ value at “just” $75.2 billion.

He added $1.5 billion to his net worth after Amazon (AMZN, Tech30) gained $9 billion in market value during trading hours Wednesday.

The company received a generous stock bump after a Barclay’s (AGRPY) analyst declared Amazon will “likely to be one of the first trillion-dollar market cap companies.” Its shares hit a record high shortly after.

Amazon’s stock has been on fire lately — it’s grown more than 16% over the last year. Investors were pleased with the company’s decision, announced yesterday, to buy Souq, an e-commerce giant in the Middle East.

Amazon isn’t Bezos’s only venture. He also owns space exploration company Blue Origin. Its goal is to eventually take people on “space tourism” trips and to deliver satellites into orbit for corporate climates. So far, the company has only conducted test flights.

Top 10 Warren Buffett Stocks To Own Right Now: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    NeoGenomics (NASDAQ:NEO) has been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $17.29.

  • [By Shane Hupp]

    NEO (CURRENCY:NEO) traded up 6.9% against the US dollar during the 24 hour period ending at 7:00 AM Eastern on April 15th. NEO has a total market cap of $4.40 billion and $88.39 million worth of NEO was traded on exchanges in the last day. One NEO coin can now be purchased for about $67.68 or 0.00809123 BTC on popular cryptocurrency exchanges including HitBTC, OKEx, Exrates and Upbit. During the last seven days, NEO has traded up 42.9% against the US dollar.

Top 10 Warren Buffett Stocks To Own Right Now: NIC Inc.(EGOV)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.

    Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.

Top 10 Warren Buffett Stocks To Own Right Now: VSE Corporation(VSEC)

Advisors’ Opinion:

  • [By Max Byerly]

    VSE (NASDAQ:VSEC) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Monday.

Top 10 Warren Buffett Stocks To Own Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

Top 10 Warren Buffett Stocks To Own Right Now: Premier, Inc.(PINC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Premier (PINC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

Top 10 Warren Buffett Stocks To Own Right Now: Liberty Global plc(LILA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dish Network (NASDAQ: DISH) and Liberty Latin America (NASDAQ:LILA) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

  • [By Ethan Ryder]

    Liberty Latin America (NASDAQ:LILA) has been assigned a consensus rating of “Hold” from the ten ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $24.75.

Top 10 Warren Buffett Stocks To Own Right Now: Yuma Energy, Inc.(YUMA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) disclosed that it received the FDA approval for Calcium Chloride injection.
    Rapid7, Inc. (NASDAQ: RPD) reported a proposed offering of 3 million shares.
    Yuma Energy Inc (NYSE: YUMA) reported a Q1 loss of $0.16 per share on sales of $5.646 million. The company also disclosed that it is actively seeking strategic alternatives.
    NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders.

  • [By Lisa Levin]

    Shares of Yuma Energy, Inc. (NYSE: YUMA) were down 60 percent to $0.4520 after the company late Friday reported it was not in compliance with its debt to EBITDAX covenant and announced limited liquidity levels. The company also reported Q1 earnings down year-over-year and disclosed that it is exploring strategic alternatives.

Top 10 Warren Buffett Stocks To Own Right Now: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By George Budwell]

    When it comes to biotech stocks, Celgene(NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) are easily two of the brightest stars. After all, these two top dogs have generated enormous returns for investors since the start of the biotech bull market back in 2010:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Gilead Sciences, Inc. (NASDAQ: GILD) which rose about 4% to $88.78. The stocks 52-week range is $63.76 to $89.54. Volume was roughly 18 million compared to the daily average volume of about 8 million.

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Keith Speights]

    AbbVie’s new hepatitis C virus (HCV) drug Mavyretappears to be giving Gilead Sciences (NASDAQ:GILD) a run for its money. In the first quarter, AbbVie’s net HCV revenue came in at $919 million. That total includes both of the company’s HCV drugs, Viekira and Mavyret. But there’s virtually no question that Mavyret is contributing most of AbbVie’s HCV revenue.

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

Top 10 Warren Buffett Stocks To Own Right Now: QuinStreet, Inc.(QNST)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn’t enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Warren Buffett Stocks To Own Right Now: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded down 9.1% against the U.S. dollar during the 24-hour period ending at 11:00 AM Eastern on May 12th. One Blue Protocol token can now be purchased for about $0.18 or 0.00002166 BTC on cryptocurrency exchanges including CoinExchange, EtherDelta (ForkDelta), IDEX and YoBit. In the last seven days, Blue Protocol has traded down 16.3% against the U.S. dollar. Blue Protocol has a market capitalization of $6.65 million and $31,443.00 worth of Blue Protocol was traded on exchanges in the last 24 hours.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.

  • [By Rafi Farber]

    Heres some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year byGilead Sciences Inc. (NASDAQ: GILD).